Table: Zeria Pharm -Q1 group results
Aug 5 (Reuters)-
Zeria Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2021 Jun 30, 2020 Mar 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 13.55 12.74 60.00
(+6.4 pct) (+13.7 pct)
Operating 1.25 1.06 4.80
(+18.3 pct) (+38.1 pct)
Recurring 2.08 632 mln 4.80
(+229.1 pct) (+49.6 pct)
Net 1.41 972 mln 3.30
(+44.8 pct) (+5.0 pct)
EPS 30.91 yen 21.02 yen 72.70 yen
Ann Div 34.00 yen 34.00 yen
-Q2 div 17.00 yen 17.00 yen
-Q4 div 17.00 yen 17.00 yen
NOTE - Zeria Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T